We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Blocking the Acsl14 Enzyme Prevents Ferroptosis-Linked Cell Death

By Gerald M. Slutzky, PhD
Posted on 25 Nov 2016
Print article
Image: A fibroblast undergoing ferroptosis (Photo courtesy of Helmholtz Zentrum München).
Image: A fibroblast undergoing ferroptosis (Photo courtesy of Helmholtz Zentrum München).
Inhibiting the enzyme Acsl4 (acyl-CoA synthetase long-chain family member 4), which is involved in fatty acid metabolism, has been postulated to be a viable therapeutic approach to preventing ferroptosis-related diseases.

Ferroptosis, a poorly understood form of programmed cell death, has been implicated in the pathological cell death found in neuronal and kidney tissues. It may also be possible to selectively trigger ferroptosis in certain cancer cells. Previously, only a few essential molecules, such as glutathione peroxidase 4 (Gpx4), have been implicated in the ferroptotic process.

Investigators at Helmholtz Zentrum München (Germany) applied two independent approaches - a genome-wide CRISPR-based genetic screen and microarray analysis of ferroptosis-resistant cell lines - to generate new details as to how ferroptosis works.

They reported in the November 14, 2016, online edition of the journal Nature Chemical Biology that ACSL4 was as an essential component for ferroptosis execution. Specifically, cells in which the genes for both Gpx4 and Acsl4 proteins had been removed showed marked resistance to ferroptosis. Mechanistically, Acsl4 enriched cellular membranes with long polyunsaturated omega-6 fatty acids. Targeting Acsl4 with thiazolidinediones, a class of antidiabetic compound, prevented tissue destruction in a mouse model of ferroptosis, Moreover, Acsl4 was preferentially expressed in a panel of basal-like breast cancer cell lines and predicted their sensitivity to ferroptosis.

"The individual mechanisms involved in this type of cell death remain only partly understood, and our findings make an important contribution towards a better understanding of ferroptotic cell death," said senior author Dr. Marcus Conrad, head of a research group at the institute of developmental genetics at the Helmholtz Zentrum München. "Our intriguing insights that the Acsl4 enzyme plays a substantial role in the process of cell death provide novel cues for yet-unrecognized therapeutic approaches towards inhibiting ferroptosis in degenerative diseases or inducing ferroptosis in certain tumor diseases. In particular, tumors that are otherwise very difficult to treat with standard chemotherapy might be amenable for ferroptosis therapy."

Related Links:
Helmholtz Zentrum München

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.